OFS Capital Sells Its Crown Jewel — and the Crown Jewel Sues Back
A $48 million BDC finally finds capital to redeploy after a year of paying down debt, but the distribution is still uncovered, the buyer of its best asset is litigating, and the redeployment targets are exactly the credit buckets public markets have spent a year de-rating.
OFS · Earnings Call · 2026-10-30
The transaction that was supposed to fix everything
OFS Capital is a $48 million market-cap BDC, and for at least four quarters its single largest problem and its single largest asset have been the same thing: an equity stake in Pfanstiehl, which management says represented roughly 35% of the portfolio at fair value as of September 30. On October 6 the company announced the sale of approximately 57% of the limited partnership interests in one of its subsidiaries, OFS SBIC I, LP, for gross proceeds of $52.3 million.
The SBIC equity transaction is the top-ranked keyword in this quarter's set and it did not exist in the prior quarter's top-30 at all — this is the genuinely new thing on the call. Bilal Rashid framed it as the culmination of a long-stated objective, calling it “a strategic step towards strengthening our balance sheet, improving liquidity, and reducing portfolio concentration risk” — Bilal Rashid, Chairman and Chief Executive Officer · 2026-10-30.
Then the plot thickened. “On October 26, Pfanstiehl filed a complaint in Delaware Chancery Court to, among other things, challenge the transaction. We believe the claim is meritless, and we intend to defend the matter vigorously.” — Bilal Rashid, Chairman and Chief Executive Officer · 2026-10-30 That is a brand-new keyword for this company — complaint in Delaware Chancery Court — and it lands on the single asset that was supposed to de-risk the story.
What makes it starker is the return math management volunteered: “What began as a relatively modest equity investment of approximately $200,000 in 2014 has generated substantial value for our shareholders over time.” — Bilal Rashid, Chairman and Chief Executive Officer · 2026-10-30 A 57% monetization of a 12-year, ~160x equity win, now subject to litigation, is a very different headline from 'we sold our concentration risk.'
The hole underneath the pivot
We posted net investment income of $719,000 or $0.05 per share for the third quarter of 2026, a decline of $0.03 per share from the second quarter... we are maintaining our quarterly distribution at $0.17 per share.
That is an uncovered distribution — $0.05 earned against $0.17 paid — and at the market price it equates to an 18.7% annualized yield. Yields that high on small BDCs are usually a statement by the equity market about sustainability, not generosity. Top-line income fell 13% to $5.9 million, and Kyle Spina was explicit that part of what held it up was “certain non-recurring interest and fee income from loan investment repayments during the quarter” — Kyle Spina, Chief Financial Officer and Treasurer · 2026-10-30. The weighted-average performing yield of 13.1% was likewise flattered by those repayments.
Book value did the rest of the damage: NAV fell to $7.38 from $8.41, a 12% quarterly decline driven by $6.8 million of depreciation on Pfanstiehl plus $3.2 million of realized and unrealized credit losses, “most pronounced in our CLO equity holdings” — Kyle Spina, Chief Financial Officer and Treasurer · 2026-10-30.
The last filed fundamentals (10-Q through late July, so they precede this quarter) already showed the strain: net income of $6 million in the June quarter against a one-year decline of roughly $11 million, and a price-to-net-income multiple near 32x. The balance sheet was already de-gearing: effective net cash of negative $182 million, up sharply over three years against liabilities at 63% of assets.
De-leveraging ends; deployment begins — into what?
OFS repaid $31.4 million of debt in the quarter and $84.8 million over twelve months, lifting regulatory asset coverage to 164%, up three points. For years the number-one keyword in this company's transcripts was debt maturities (it topped the list in early 2026); this quarter it vanishes from the top-30 entirely, replaced by the assertion that the earliest maturity now sits in 2028. The asset coverage ratio has become the company's proof point rather than its worry.
The uncomfortable second half of the pivot is where the $52.3 million goes. Management now leans hard on the breadth of investment capabilities across its adviser's platform — infrastructure credit, real estate credit, asset-backed finance, liquid credit, structured credit — while treating traditional middle market lending as merely one option among many. New deployment was just $7.7 million in the quarter, so this is entirely prospective.
Here is the tension. The global price tape shows asset based finance as one of the worst-performing theme clusters over 360 days — a basket of BX, ARES, TPG, CG, RITM, APO, AB, KKR and FSK down roughly 16% — and real estate credit down about 20% over the same window. OFS is steering fresh capital into precisely the credit categories public equity has spent a year de-rating. That may be exactly when private credit returns are best; but the tape is not voting with them.
The offsetting argument is rates. Rashid expects “the recent increase in base rates will be accretive to our earnings on a going-forward basis” — Bilal Rashid, Chairman and Chief Executive Officer · 2026-10-30, echoing the market-wide Fed rate hike narrative that dominated the global keyword set this quarter. Note the contrast with the banks that reported alongside OFS — they were consumed by cost of deposits and core deposits. OFS is the other side of that trade: a floating-rate lender that wants higher base rates.
Credit quality: the drumbeat that never stops
Two borrowers were placed on non accrual status in Q3, totaling $2.1 million at fair value, while one prior non-accrual was resolved. This is emphatically not new: non-accrual has been a top-three company keyword in six or more of the last twelve quarters, ranking first in both 2026Q2 and 2026Q3 and second in early 2024. What is mildly encouraging is the texture — one of the new non-accruals is still paying contractually and was moved on internal risk assessment, and the portfolio remains 97% first-lien by fair value. The capital preservation framing is genuine, not decorative.
Nobody is asking questions
The most telling detail is not in the prepared remarks. Across the last three quarters, the Q&A session consisted of an operator opening the line and closing it again: “Showing no questions. This will conclude our question and answer session as well as the conference call.” — Operator · 2026-03-03 And in July, “And that does conclude our question-and-answer session and today's conference call.” — Operator, Operator · 2026-07-31 Zero analyst engagement on a name paying an 18.7% yield and now defending a sale of its largest asset in Chancery Court.
The tape reflects that thinness. OFS is up 8.3% over the last 90 trading days — but sits 15.9% below its October 8 peak of $4.27, and the long arc is brutal: down 75% since 2012 with a 76% drawdown from its 2017 high of $15.22.
The verdict. Rashid calls this “an important inflection point for OFS Capital” — Bilal Rashid, Chairman and Chief Executive Officer · 2026-10-30, and structurally he is not wrong — this is the first quarter in years where the company has capital to deploy rather than debt to retire. But the inflection is unfunded by earnings: distribution coverage is a third, the redeployment universe overlaps the market's most-hated credit themes, and the counterparty on the crown-jewel sale is now an adversary. The one number to watch is Q4 net investment income off a $0.05 base.